[1]肖岑昕,黄恒青.肠道微生物群与慢性病毒性肝炎的关系[J].医学信息,2021,34(21):39-41.[doi:10.3969/j.issn.1006-1959.2021.21.009]
 XIAO Cen-xin,HUANG Heng-qing.Relationship Between Intestinal Microflora and Chronic Viral Hepatitis[J].Medical Information,2021,34(21):39-41.[doi:10.3969/j.issn.1006-1959.2021.21.009]
点击复制

肠道微生物群与慢性病毒性肝炎的关系()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年21期
页码:
39-41
栏目:
综述
出版日期:
2021-11-01

文章信息/Info

Title:
Relationship Between Intestinal Microflora and Chronic Viral Hepatitis
文章编号:
1006-1959(2021)21-0039-03
作者:
肖岑昕黄恒青
(1.福建中医药大学第二临床医学院,福建 福州 350122;2.福建中医药大学附属第二人民医院脾胃病科,福建 福州 350003)
Author(s):
XIAO Cen-xinHUANG Heng-qing
(1.The Second Clinical Medical College of Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China;2.Department of Gastroenterology,the Second People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou 3
关键词:
肠道微生物群慢性病毒性肝炎乙型肝炎丙型肝炎
Keywords:
Intestinal microfloraChronic viral hepatitisHepatitis BHepatitis C
分类号:
R512.6
DOI:
10.3969/j.issn.1006-1959.2021.21.009
文献标志码:
A
摘要:
肠道微生物群参与多种疾病的调控,肠-肝轴理论提出为肠道微生物群和肝脏疾病的关系提供的新的思路。乙、丙、丁型病毒性肝炎多呈慢性感染,长期未予控制,可发展为肝硬化、肝癌等。因此,研究肠道微生物群与慢性病毒性肝炎之间的关系具有重要意义。目前研究多集中于对乙型、丙型病毒肝炎,本文现对慢性乙型、丙型病毒性肝炎与肠道微生物群的关系进行综述,以期为指导疾病的防治,改善患者的生存预后提供参考。
Abstract:
Intestinal microflora has been proved to be involved in the regulation of many diseases. The gut-liver axis theory provides a new idea for the relationship between gut microbiota and liver diseases. Hepatitis B, C, D are chronic infected, and long-term uncontrolled, which will finally be malignantly transformed into cirrhosis, liver cancer. Therefore, it is of great significance to study the relationship between intestinal microflora and chronic viral hepatitis. At present, most studies focus on viral hepatitis B and C. This paper reviews the relationship between chronic viral hepatitis B and C and intestinal microflora, in order to guide the prevention and treatment of diseases and improve the prognosis of patients.

参考文献/References:

[1]徐小元,丁惠国,李文刚,等.肝硬化诊治指南[J].实用肝脏病杂志,2019,22(6):770-786.[2]Shi N,Li N,Duan X,et al.Interaction between the gut microbiome and mucosal immune system[J].Mil Med Res,2017(4):14.[3]Sittipo P,Lobionda S,Lee YK,et al.Intestinal microbiota and the immune system in metabolic diseases[J].J Microbiol,2018,56(3):154-162.[4]Lazar V,Ditu LM,Pircalabioru GG,et al.Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer[J].Front Immunol,2018(9):1830.[5]Robertson RC,Manges AR,Finlay BB,et al.The Human Microbiome and Child Growth-First 1000 Days and Beyond[J].Trends Microbiol,2019,27(2):131-147.[6]O’Hara SP,Karlsen TH,LaRusso NF.Cholangiocytes and the environment inprimary sclerosing cholangitis: where is the link?[J].Gut,2017,66(11):1873-1877.[7]Carotti S,Guarino MP,Vespasiani-Gentilucci U,et al.Starring role of toll-like receptor-4 activation in the gut-liver axis[J].World J Gastrointest Pathophysiol,2015,6(4):99-109.[8]王贵强,王福生,庄辉,等.慢性乙型肝炎防治指南(2019年版)[J].中国病毒病杂志,2020,10(1):1-25.[9]Chou HH,Chien WH,Wu LL,et al.Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota[J].Proc Natl Acad Sci USA,2015,112(7):2175-2180.[10]Yun Y,Chang Y,Kim HN,et al.Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level[J].J Clin Med,2019,8(2):173.[11]Gasaly N,Hermoso MA,Gotteland M.Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases[J].Int J Mol Sci,2021,22(6):3061.[12]Zeng Y,Chen S,Fu Y,et al.Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma[J].J Viral Hepat,2020,27(2):143-155.[13]Wei X,Yan X,Zou D,et al.Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach[J].BMC Gastroenterol,2013(13):175.[14]Thilakarathna WPDW,Rupasinghe HPV,Ridgway ND.Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma[J].Int J Mol Sci,2021,22(5):2606.[15]Ling Z,Liu X,Cheng Y,et al.Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project[J].Sci Rep,2015(5):17098.[16]Zhao Y,Mao YF,Tang YS,et al.Altered oral microbiota in chronic hepatitis B patients with different tongue coatings[J].World J Gastroenterol,2018,24(30):3448-3461.[17]WHO.Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection[M].Geneva: World Health Organization,2018.[18]Sehgal R,Bedi O,Trehanpati N.Role of Microbiota in Pathogenesis and Management of Viral Hepatitis[J].Front Cell Infect Microbiol,2020(10):341.[19]Aly AM,Adel A,El-Gendy AO,et al.Gut microbiome alterations inpatients with stage 4 hepatitis C[J].Gut Pathog,2016,8(1):42.[20]Hetta HF.Gut immune response in the presence of hepatitis C virus infection[J].World Journal of Immunology,2014,4(2):52.[21]Maeda Y,Kurakawa T,Umemoto E,et al.Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine[J].Arthritis Rheumatol,2016,68(11):2646-2661.[22]Abou El-Khier NT,Elhammady D,Arafa MM,et al.Th17 and IL-17 as Predictors of Hepatic Inflammation in Patients with Chronic Hepatitis C Virus Infection and Treated With Direct Antiviral Therapy[J].Egypt J Immunol,2018,25(2):61-74.[23]Loo YT,Howell K,Chan M,et al.Modulation of the human gut microbiota by phenolics and phenolic fiber-rich foods[J].Compr Rev Food Sci Food Saf,2020,19(4):1268-1298.[24]Oo KM,Lwin AA,Kyaw YY,et al.Safety and long-term effect of the probiotic FK-23 in patients with hepatitis Cvirus infection[J].Biosci Microbiota Food Health,2016,35(3):123-128.[25]Wu Y,Li X,Tan F,et al.Lactobacillus fermentum CQPC07attenuates obesity, inflammation and dyslipidemia by modulating the antioxidantcapacity and lipid metabolism in high-fat diet induced obese mice[J].J Inflamm(Lond),2021,18(1):5.[26]Heidrich B,Vital M,Plumeier I,et al.Intestinalmicrobiota in patients with chronic hepatitis C with and without cirrhosiscompared with healthy controls[J].Liver Int,2018,38(1):50-58.[27]Inoue T,Nakayama J,Moriya K,et al.Gut Dysbiosis Associated WithHepatitis C Virus Infection[J].Clin Infect Dis,2018,67(6):869-877.[28]Li JM,Yu R,Zhang LP,et al.Dietaryfructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: abenefit of short-chain fatty acids[J].Microbiome,2019,7(1):98.[29]Prince PD,Lanzi CR,Toblli JE,et al.Dietary (-)-epicatechin mitigates oxidative stress, NO metabolism alterations,and inflammation in renal cortex from fructose-fed rats[J].Free Radic Biol Med,2016(90):35-46.[30]Alexopoulou A,Agiasotelli D,Vasilieva LE,et al.Bacterialtranslocation markers in liver cirrhosis[J].Ann Gastroenterol,2017,30(5):486-497.

更新日期/Last Update: 1900-01-01